Digital transformation has been dramatically accelerated by the Covid-19 pandemic, requiring businesses and operations to quickly set up infrastructures to maintain business continuity.
As we emerge from the pandemic, organizations are now more…
Source: www.cshub.com and Read More
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
